EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV

Scott Grossman iD, Colin W G Fishwick, Martin J McPhillie

Pharmaceuticals · 08.02.2023 · 16 (2) · 261

DOI: 10.3390/ph16020261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 08.02.2023. Verfasst von Scott Grossman und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Leeds, Leeds LS2 9JT, UK. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, BBSRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increases in antibiotic usage and antimicrobial resistance occurrence have caused a dramatic reduction in the effectiveness of many frontline antimicrobial treatments. Topoisomerase inhibitors including fluoroquinolones are broad-spectrum antibiotics used to treat a range of infections, which stabilise a topoisomerase-DNA cleavage complex via intercalation of the bound DNA. However, these are subject to bacterial resistance, predominantly in the form of single-nucleotide polymorphisms in the active site. Significant research has been undertaken searching for novel bioactive molecules capable of inhibiting bacterial topoisomerases at sites distal to the fluoroquinolone binding site. Notably, researchers have undertaken searches for anti-infective agents that can inhibit topoisomerases through alternate mechanisms. This review summarises work looking at the inhibition of topoisomerases predominantly through non-intercalating agents, including those acting at a novel allosteric site, ATPase domain inhibitors, and those offering unique binding modes and mechanisms of action.

Schlagwörter

Stichwörter der Autor:innen

ATPaseDNA gyraseallostericantibiotictopo IVtopoisomerase

Autor:innen und Institutionen

  • School of Chemistry, University of Leeds, Leeds LS2 9JT, UK.

ORCID-Profile: Scott Grossman

Förderung

  • Biotechnology and Biological Sciences Research Council
  • BBSRC

Zitieren

APA

Grossman, S., Fishwick, C. W. G., & McPhillie, M. J. (2023). Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV. Pharmaceuticals, 16(2), 261. https://doi.org/10.3390/ph16020261

Vancouver

Grossman S, Fishwick CWG, McPhillie MJ. Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV. Pharmaceuticals. 2023;16(2):261. doi:10.3390/ph16020261

BibTeX
@article{Grossman2023,
  author = {Grossman, Scott and Fishwick, Colin W G and McPhillie, Martin J},
  title = {Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {261},
  doi = {10.3390/ph16020261}
}
Kostenlos starten →